| Form | Liquid |
|---|
| Isotype | Fusion - [ICOSLG N-terminal fragment (1-122)]2 - I |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G purified from cell culture supernatant. |
|---|
| Concentration | 1mg/ml |
|---|
| Endotoxin Level | Please contact the lab for this information. |
|---|
| Applications | ELISA, Functional assay, Research in vivo |
|---|
| Species Reactivity | Human |
|---|
| Target | CD28, TP44, T-cell-specific surface glycoprotein CD28, CD278, ICOS, Inducible T-cell costimulator, Activation-inducible lymphocyte immunomediatory molecule, AILIM |
|---|
| Storage Buffer | 0.01M PBS, pH 7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
|---|
| Expression System | Mammalian Cells |
|---|
| Accession Number | P10747 & Q9Y6W8 |
|---|
| Background | Acazicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell costimulator (ICOS)/CD28 antagonist. Acazicolcept has anti-inflammatory activities.
|
|---|
| Alternative Names | ALPN-101, ICOSLvIgD-Fc, 2270247-50-0 |
|---|
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|---|